When making the decision to invest in ELTP for the long-term, I look at the amount shares offered to compensate Jerry Treppel and the rest of management and made a fair assumption that they would be committed and motivated to build the company from the ground and up. I'm not concerned with the amount of shares in the "truckloads" or "boatloads" that investors disclosed for the purpose of short-term investment. The current due diligence compiled and contributed to the Ihub board is not intended to mislead but to educate Elite Pharmaceuticals from investors' perspective as we witness the evolution of Elite from near the brink of bankruptcy to successfully being awarded a couple key patents that would pave the future of the company. A vital trait of successful long-term, value investor is the ability to be forward-thinking and to see pass the noise of realizing Elite Pharmaceutical's true value. Cheers!
Market Data 
Markets 
AI
